エピソード

  • Stakeholder Expectations and Collaboration in the Evolving Healthcare Landscape: R&D Expectations
    2020/01/20

    It's sometimes challenging to find insights that are actionable in development. In this podcast, Iris Loew-Friendish, UCB Chief Medical Officer and member of the UCB Executive Committee and UCB Head of Development in Medical Practice, highlights her personal journey to help you understand how Medical Affairs is uniquely suited to address these issues.

    続きを読む 一部表示
    8 分
  • Stakeholder Expectations and Collaboration in the Evolving Healthcare Landscape: ep 2 R&D Expectations
    2020/02/11

    It's sometimes challenging to find insights that are actionable in development. In this podcast, Prof. Dr. med. Iris Loew-Friedrich, UCB Chief Medical Officer and member of the UCB Executive Committee and UCB Head of Development in Medical Practice, highlights her personal journey to help you understand how Medical Affairs is uniquely suited to address these issues.

    続きを読む 一部表示
    8 分
  • Stakeholder Expectations and Collaboration in the Evolving Healthcare Landscape: ep 5 Partnering with Commercial R&D
    2020/02/11

    In theory, successfully commercializing a product is straightforward; in reality it is not. In this comprehensive discussion, Matthew McLoughlin, MD, ex-Head of Advisory Services and Head of the Executive Committee for Kinapse is joined by Gustavo Kesselring MD, current Academy Vice President for the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) to discuss evidence generation to meet the needs of external stakeholders, the ability to bring actionable insights into the company, and the need for revamping of knowledge acquisition.

    続きを読む 一部表示
    19 分
  • Stakeholder Expectations in the Evolving Healthcare Landscape: ep 1 Patient Centricity
    2020/02/19

    Patients want the best medicine and therapy available. Merinke Kuiper-Lenters, MD, a physician and patient who was diagnosed with autoimmune vasculitis, explains patient expectations from the pharma industry.

    続きを読む 一部表示
    11 分
  • Stakeholder Expectations and Collaboration in the Evolving Healthcare Landscape: ep 3 Commercial Engagement
    2020/02/19

    What does the future of MA look like from a commercial perspective? Robert "Bobby" Mulrooney, MD, General Manager, UK & Ireland for Portola Pharmaceuticals, shares his candid opinions as to how MA can be a driver of strategy with commercial partners.

    続きを読む 一部表示
    15 分
  • Stakeholder Expectations and Collaboration in the Evolving Healthcare Landscape: ep 4 From Global to Local
    2020/02/19

    How can global leaders set affiliates up for success? Charlotte Kremer MD MBA, EVP of Medical Affairs for Astellas, and current MAPS President, speaks to the importance of sharing information in real time.

    続きを読む 一部表示
    5 分
  • The Dynamic World of Field Medical: Are you a driver or passenger? ep 1 Objectives, panel introductions and what to expect at the MAPS Annual Global Meeting on March 8th
    2020/02/24

    Host Robin Winter-Sperry MD, Head of Global Field Based Medical Excellence & Insights at Sanofi Genzyme introduces Donna Holder PharmD, Executive Director, Global Field Medical Center of Excellence (CoE) at Merck, and Ralph Rewers PharmD, AbbVie’s Global Head, Field Medical Excellence who organized this specialized course that is being offered at the MAPS annual meeting on March 8 in Miami.

    続きを読む 一部表示
    9 分
  • The Dynamic World of Field Medical: Are you a driver or passenger? ep 2 MSL: Why specialized training is a requirement and not optional.
    2020/02/24

    Are you keeping up with the data and science that are driving the profession? The panelists who will be highlighting the critical importance of adult learning principles and certification of knowledge to career training insights on March 8 in Miami are: Donna Holder, PharmD, Executive Director, Global Field Medical Center of Excellence (CoE) at Merck, Stephen Valerio, MS, CMP, AstraZeneca Senior Director of Oncology Medical Training, Urvashi Vashee, PharmD, Team Lead Director, Global Scientific Training Oncology at Merck & Co, and Danielle C. Heuer, Director of WD Communications.

    続きを読む 一部表示
    7 分